NM_178335.3:c.49+20A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_178335.3(CCDC50):​c.49+20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.574 in 1,602,756 control chromosomes in the GnomAD database, including 272,951 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.66 ( 35098 hom., cov: 32)
Exomes 𝑓: 0.56 ( 237853 hom. )

Consequence

CCDC50
NM_178335.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0330

Publications

11 publications found
Variant links:
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-191329743-A-G is Benign according to our data. Variant chr3-191329743-A-G is described in ClinVar as [Benign]. Clinvar id is 262931.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.898 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC50NM_178335.3 linkc.49+20A>G intron_variant Intron 1 of 11 ENST00000392455.9 NP_848018.1 Q8IVM0-2
UTS2BNM_198152.5 linkc.-665+671T>C intron_variant Intron 1 of 8 ENST00000340524.10 NP_937795.2 Q765I0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC50ENST00000392455.9 linkc.49+20A>G intron_variant Intron 1 of 11 1 NM_178335.3 ENSP00000376249.4 Q8IVM0-2
UTS2BENST00000340524.10 linkc.-665+671T>C intron_variant Intron 1 of 8 2 NM_198152.5 ENSP00000340526.5 Q765I0

Frequencies

GnomAD3 genomes
AF:
0.662
AC:
100635
AN:
151936
Hom.:
35053
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.859
Gnomad AMI
AF:
0.343
Gnomad AMR
AF:
0.705
Gnomad ASJ
AF:
0.548
Gnomad EAS
AF:
0.920
Gnomad SAS
AF:
0.693
Gnomad FIN
AF:
0.573
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.537
Gnomad OTH
AF:
0.621
GnomAD2 exomes
AF:
0.641
AC:
144582
AN:
225496
AF XY:
0.628
show subpopulations
Gnomad AFR exome
AF:
0.864
Gnomad AMR exome
AF:
0.777
Gnomad ASJ exome
AF:
0.547
Gnomad EAS exome
AF:
0.932
Gnomad FIN exome
AF:
0.571
Gnomad NFE exome
AF:
0.531
Gnomad OTH exome
AF:
0.598
GnomAD4 exome
AF:
0.565
AC:
819386
AN:
1450702
Hom.:
237853
Cov.:
38
AF XY:
0.566
AC XY:
408022
AN XY:
720628
show subpopulations
African (AFR)
AF:
0.867
AC:
28814
AN:
33222
American (AMR)
AF:
0.769
AC:
33277
AN:
43264
Ashkenazi Jewish (ASJ)
AF:
0.547
AC:
14133
AN:
25842
East Asian (EAS)
AF:
0.897
AC:
35179
AN:
39232
South Asian (SAS)
AF:
0.677
AC:
56974
AN:
84190
European-Finnish (FIN)
AF:
0.567
AC:
29570
AN:
52134
Middle Eastern (MID)
AF:
0.527
AC:
3021
AN:
5736
European-Non Finnish (NFE)
AF:
0.527
AC:
582979
AN:
1107176
Other (OTH)
AF:
0.592
AC:
35439
AN:
59906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
15945
31890
47834
63779
79724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16944
33888
50832
67776
84720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.662
AC:
100734
AN:
152054
Hom.:
35098
Cov.:
32
AF XY:
0.668
AC XY:
49674
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.859
AC:
35671
AN:
41536
American (AMR)
AF:
0.706
AC:
10786
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.548
AC:
1903
AN:
3470
East Asian (EAS)
AF:
0.920
AC:
4743
AN:
5156
South Asian (SAS)
AF:
0.693
AC:
3339
AN:
4818
European-Finnish (FIN)
AF:
0.573
AC:
6051
AN:
10568
Middle Eastern (MID)
AF:
0.599
AC:
176
AN:
294
European-Non Finnish (NFE)
AF:
0.537
AC:
36442
AN:
67902
Other (OTH)
AF:
0.621
AC:
1312
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1622
3245
4867
6490
8112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
5118
Bravo
AF:
0.683
Asia WGS
AF:
0.802
AC:
2782
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
5.7
DANN
Benign
0.66
PhyloP100
-0.033
PromoterAI
0.048
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9847278; hg19: chr3-191047532; API